Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos

Detalhes bibliográficos
Autor(a) principal: Dellacqua, Melissa Negro
Data de Publicação: 2012
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFPB
Texto Completo: https://repositorio.ufpb.br/jspui/handle/tede/6739
Resumo: The aim of the present study was to evaluate the cardiovascular effects of Garziera red wine (Shiraz grape, vintage 2005) (GASH) of the Vale do São Francisco (Pernambuco Brazil) by using in vitro and in vivo approaches. Measurements of polyphenols levels in GASH revealed high levels of total phenolics compounds, quercetin and cis- and trans-resveratrol. Acute toxicity tests showed that GASH presented toxic effects only at doses 10-fold higher than the doses used in the in vivo experiments. Oral treatment with GASH at dose of 100 mg/kg/day for 7 days in normotensive rats did not promote significant differences in MAP and HR group treated with GASH (mmHg= 119.0 ± 2.02) compared to the control group (mmHg= 120.20 ± 2.04). In nonanesthetized SHR rats treated orally with GASH for 21 days at dose of 100 mg/kg/day, GASH decreased the MAP in the group treated (mmHg= 122.7 ± 1.52) compared to the control group (mmHg= 156.0 ± 5.39) and there was no change in HR. Similar results occurred with SHR rats and L-NAME hypertensive rats treated with GASH at dose of 100 mg/kg/day for 7 days, but the treatment for 21 days provides a greater reduction in the MAP. In non-anesthetized SHR rats, i.v administration of GASH promoted a biphasic effect, initially characterized by hypotension (ΔMAP= -39.40 ± 11.62) and bradycardia (ΔHR= -96.06 ± 44.34) followed by hypertension (ΔMAP= 69.4 ± 15.82) and tachycardia (ΔHR = 74.4 ± 35.95). Similar results occurred with LNAME hypertensive rats and normotensive rats. When comparing the results, the decrease in MAP is greater, and the bradycardia is smaller, in the L-NAME model and SHR model compared to normotensive rats. For the evaluation of hypotension and bradycardia in vivo, we performed the previous administration of L-NAME and atropine in normotensive rats and the hypotensive effect was attenuated and the bradycardia was abolished. Subsequently, experiments in rings of superior mesenteric artery isolated from normotensive rats showed that GASH-induced relaxation (Emax= 87.5 ± 6.5%) was significantly attenuated after removal of functional endothelium (Emax= 28.4 ± 4.9%), suggesting the involvement of endothelial-derived relaxing factors. Similar results were obtained with the previous incubation with L-NAME (Emax= 23.4 ± 5.1%) and ODQ (Emax= 11.8 ± 2.7%), suggesting the involvement of the NOS/NO/GMPc pathway in the relaxation. In rings of superior mesenteric artery isolated from normotensive rat, the previous incubation with indomethacin (Emax= 97 ± 4.1%) and atropine (Emax= 81 ± 3.9%) did not modify the relaxation induced by GASH, suggesting that arachidonic acid metabolites and M3 muscarinic receptor activation are not involved in this response. In endothelial cell line from rabbit aorta, GASH increased NO production (Δ= 82 ± 7.9%), which was reduced in the presence of L-NAME (Δ= 30.2 ± 12.1%), confirming the functional results. GASH promote the phosphorylation of eNOs and Akt in primary culture of endothelial cells from pig coronary by Western blot. Previous incubation with N-acetylcysteine in rings of superior mesenteric artery isolated from normotensive rats modified the relaxation induced by GASH (Emax= 32.5 ± 6.7%), suggesting the involvement of reactive oxygen species in the relaxation. GASH was able to increase levels of superoxide production in RAEC cell culture (Δ= 57 ± 4%). Using different methodological approaches in vivo and in vitro, this study suggests that GASH induces a antihypertensive effect in vivo in different models of hypertension, as well as an endothelium-dependent relaxing effect, probably secondary to an increase in the concentration of NO through the activation of the PI3k/Akt via, and suggest that these effects may be associated with the content of phenolic compounds found in GASH.
id UFPB_772dc4b12a8a2e9ae4eb00dcc358f992
oai_identifier_str oai:repositorio.ufpb.br:tede/6739
network_acronym_str UFPB
network_name_str Biblioteca Digital de Teses e Dissertações da UFPB
repository_id_str
spelling Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratosEvaluation of cardiovascular effects induced by Garziera red wine lyophilized of Vale do São Francisco in rats.Vinho tintoHipotensãoRelaxamentoÓxido nítricoRed wineHypotensionRelaxationNitric oxideCIENCIAS BIOLOGICAS::FARMACOLOGIAThe aim of the present study was to evaluate the cardiovascular effects of Garziera red wine (Shiraz grape, vintage 2005) (GASH) of the Vale do São Francisco (Pernambuco Brazil) by using in vitro and in vivo approaches. Measurements of polyphenols levels in GASH revealed high levels of total phenolics compounds, quercetin and cis- and trans-resveratrol. Acute toxicity tests showed that GASH presented toxic effects only at doses 10-fold higher than the doses used in the in vivo experiments. Oral treatment with GASH at dose of 100 mg/kg/day for 7 days in normotensive rats did not promote significant differences in MAP and HR group treated with GASH (mmHg= 119.0 ± 2.02) compared to the control group (mmHg= 120.20 ± 2.04). In nonanesthetized SHR rats treated orally with GASH for 21 days at dose of 100 mg/kg/day, GASH decreased the MAP in the group treated (mmHg= 122.7 ± 1.52) compared to the control group (mmHg= 156.0 ± 5.39) and there was no change in HR. Similar results occurred with SHR rats and L-NAME hypertensive rats treated with GASH at dose of 100 mg/kg/day for 7 days, but the treatment for 21 days provides a greater reduction in the MAP. In non-anesthetized SHR rats, i.v administration of GASH promoted a biphasic effect, initially characterized by hypotension (ΔMAP= -39.40 ± 11.62) and bradycardia (ΔHR= -96.06 ± 44.34) followed by hypertension (ΔMAP= 69.4 ± 15.82) and tachycardia (ΔHR = 74.4 ± 35.95). Similar results occurred with LNAME hypertensive rats and normotensive rats. When comparing the results, the decrease in MAP is greater, and the bradycardia is smaller, in the L-NAME model and SHR model compared to normotensive rats. For the evaluation of hypotension and bradycardia in vivo, we performed the previous administration of L-NAME and atropine in normotensive rats and the hypotensive effect was attenuated and the bradycardia was abolished. Subsequently, experiments in rings of superior mesenteric artery isolated from normotensive rats showed that GASH-induced relaxation (Emax= 87.5 ± 6.5%) was significantly attenuated after removal of functional endothelium (Emax= 28.4 ± 4.9%), suggesting the involvement of endothelial-derived relaxing factors. Similar results were obtained with the previous incubation with L-NAME (Emax= 23.4 ± 5.1%) and ODQ (Emax= 11.8 ± 2.7%), suggesting the involvement of the NOS/NO/GMPc pathway in the relaxation. In rings of superior mesenteric artery isolated from normotensive rat, the previous incubation with indomethacin (Emax= 97 ± 4.1%) and atropine (Emax= 81 ± 3.9%) did not modify the relaxation induced by GASH, suggesting that arachidonic acid metabolites and M3 muscarinic receptor activation are not involved in this response. In endothelial cell line from rabbit aorta, GASH increased NO production (Δ= 82 ± 7.9%), which was reduced in the presence of L-NAME (Δ= 30.2 ± 12.1%), confirming the functional results. GASH promote the phosphorylation of eNOs and Akt in primary culture of endothelial cells from pig coronary by Western blot. Previous incubation with N-acetylcysteine in rings of superior mesenteric artery isolated from normotensive rats modified the relaxation induced by GASH (Emax= 32.5 ± 6.7%), suggesting the involvement of reactive oxygen species in the relaxation. GASH was able to increase levels of superoxide production in RAEC cell culture (Δ= 57 ± 4%). Using different methodological approaches in vivo and in vitro, this study suggests that GASH induces a antihypertensive effect in vivo in different models of hypertension, as well as an endothelium-dependent relaxing effect, probably secondary to an increase in the concentration of NO through the activation of the PI3k/Akt via, and suggest that these effects may be associated with the content of phenolic compounds found in GASH.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESO objetivo do presente estudo foi avaliar os efeitos cardiovasculares do vinho tinto Garziera (Cepa Shiraz, safra 2005) (GASH) do Vale do São Francisco (PE Brasil), utilizando metodologias in vitro e in vivo. Níveis de polifenóis no GASH foram medidos e GASH apresentou altos níveis de fenólicos totais e altos níveis de quercetina e de cis e trans-resveratrol. Os testes de toxicidade aguda mostraram que GASH apresentou efeito tóxico apenas em doses dez vezes maiores do que as doses utilizadas nos experimentos. O tratamento via oral com GASH por 7 dias na dose de 100 mg/kg/dia em animais normotensos não promoveu diferença na PAM e FC do grupo tratado com GASH (mmHg= 119,0 ± 2,02) em comparação ao grupo controle (mmHg = 120,20 ± 2,04). Em ratos hipertensos SHR não anestesiados tratados com GASH por 21 dias na dose de 100 mg/kg/dia, GASH diminuiu a PAM do grupo tratado (mmHg= 122,7 ± 1,52) em comparação ao grupo controle (mmHg= 156,0 ± 5,39), não ocorrendo modificação da FC. Resultados semelhantes ocorreram com ratos SHR e ratos hipertensos L-NAME tratados com GASH na dose de 100 mg/kg/dia durante 7 dias, mas o tratamento durante 21 dias proporcionou maior queda na PAM. A administração i.v. de GASH na dose de 75 mg/kg em ratos SHR desencadeou um efeito bifásico, caracterizado inicialmente por hipotensão (ΔPAM= -39,40 ± 11,62) e bradicardia (ΔFC= -96,06 ± 44,34) seguido de hipertensão (ΔPAM= 69,4 ± 15,82) e taquicardia (ΔFC= 74,4 ± 35,95). Resultados semelhantes ocorreram com ratos hipertensos LNAME e ratos normotensos. Quando se compara os resultados, a queda da PAM é maior, e a bradicardia é menor, no modelo L-NAME e SHR em relação ao rato normotenso. Para avaliação da hipotensão e bradicardia in vivo, realizamos a administração prévia de L-NAME e atropina em ratos normotensos, e a resposta hipotensora foi atenuada e a bradicardia foi abolida. Seguidamente, experimentos em anéis de artéria mesentérica superior isolada de rato normotenso mostraram que GASH induziu relaxamento (Emáx= 87,5 ± 6,5%) que foi significantemente atenuado após a remoção do endotélio funcional (Emáx= 28,4 ± 4,9%), sugerindo a participação de fatores relaxantes endoteliais. Resultados similares foram obtidos com a incubação prévia de L-NAME (Emáx= 23,4 ± 5,1%) e ODQ (Emáx= 11,8 ± 2,7%), sugerindo o envolvimento da via NOS/NO/GMPc no relaxamento. Em anéis de artéria mesentérica superior isolada de rato normotenso, a incubação prévia com indometacina (Emáx= 97 ± 4,1%), e atropina (Emáx= 81 ± 3,9%), não modificou o relaxamento induzido pelo GASH, sugerindo que os metabólitos do ácido araquidônico e a ativação do receptor muscarínico M3 não estão envolvidos nesta resposta. Em linhagem de células endoteliais da aorta de coelho, GASH aumentou a produção de NO (Δ= 82 ± 7,9%), que foi diminuída na presença de L-NAME (Δ= 30,2 ± 12,1%), corroborando os resultados funcionais. GASH promoveu a fosforilação da eNOS e da Akt em cultura primária de células endoteliais de coronária de porco por metodologia de Western blot. A incubação prévia com N-acetilcisteína em anéis de artéria mesentérica superior isolada de ratos normotensos modificou o relaxamento induzido pelo GASH (Emáx= 32,5 ± 6,7%) sugerindo o envolvimento de ROS neste relaxamento. GASH foi capaz de aumentar os níveis de produção de superóxido em cultura de células RAEC (Δ= 57 ± 4%). Este estudo, que fez uso de diferentes abordagens metodológicas in vivo e in vitro, sugere GASH induz um efeito anti-hipertensivo in vivo em modelos diferenciados de hipertensão e apresenta efeito relaxante dependente de endotélio, provavelmente secundário a um aumento na concentração de NO através da ativação da via PI3k/Akt, e que estes efeitos podem estar associados com o conteúdo de compostos fenólicos encontrados no GASH.Universidade Federal da Paraí­baBRFarmacologiaPrograma de Pós-Graduação em Produtos Naturais e Sintéticos BioativosUFPBMedeiros, Isac Almeida dehttp://lattes.cnpq.br/3412816427200150Dellacqua, Melissa Negro2015-05-14T12:59:37Z2018-07-21T00:24:52Z2012-09-112018-07-21T00:24:52Z2012-02-14info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfDELLACQUA, Melissa Negro. Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos. 2012. 124 f. Tese (Doutorado em Produtos Naturais e Sintéticos Bioativos) - Universidade Federal da Paraí­ba, João Pessoa, 2012.https://repositorio.ufpb.br/jspui/handle/tede/6739porinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2020-02-24T21:52:24Zoai:repositorio.ufpb.br:tede/6739Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufpb.br/PUBhttp://tede.biblioteca.ufpb.br:8080/oai/requestdiretoria@ufpb.br|| diretoria@ufpb.bropendoar:2020-02-24T21:52:24Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
Evaluation of cardiovascular effects induced by Garziera red wine lyophilized of Vale do São Francisco in rats.
title Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
spellingShingle Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
Dellacqua, Melissa Negro
Vinho tinto
Hipotensão
Relaxamento
Óxido nítrico
Red wine
Hypotension
Relaxation
Nitric oxide
CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
title_full Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
title_fullStr Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
title_full_unstemmed Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
title_sort Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos
author Dellacqua, Melissa Negro
author_facet Dellacqua, Melissa Negro
author_role author
dc.contributor.none.fl_str_mv Medeiros, Isac Almeida de
http://lattes.cnpq.br/3412816427200150
dc.contributor.author.fl_str_mv Dellacqua, Melissa Negro
dc.subject.por.fl_str_mv Vinho tinto
Hipotensão
Relaxamento
Óxido nítrico
Red wine
Hypotension
Relaxation
Nitric oxide
CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Vinho tinto
Hipotensão
Relaxamento
Óxido nítrico
Red wine
Hypotension
Relaxation
Nitric oxide
CIENCIAS BIOLOGICAS::FARMACOLOGIA
description The aim of the present study was to evaluate the cardiovascular effects of Garziera red wine (Shiraz grape, vintage 2005) (GASH) of the Vale do São Francisco (Pernambuco Brazil) by using in vitro and in vivo approaches. Measurements of polyphenols levels in GASH revealed high levels of total phenolics compounds, quercetin and cis- and trans-resveratrol. Acute toxicity tests showed that GASH presented toxic effects only at doses 10-fold higher than the doses used in the in vivo experiments. Oral treatment with GASH at dose of 100 mg/kg/day for 7 days in normotensive rats did not promote significant differences in MAP and HR group treated with GASH (mmHg= 119.0 ± 2.02) compared to the control group (mmHg= 120.20 ± 2.04). In nonanesthetized SHR rats treated orally with GASH for 21 days at dose of 100 mg/kg/day, GASH decreased the MAP in the group treated (mmHg= 122.7 ± 1.52) compared to the control group (mmHg= 156.0 ± 5.39) and there was no change in HR. Similar results occurred with SHR rats and L-NAME hypertensive rats treated with GASH at dose of 100 mg/kg/day for 7 days, but the treatment for 21 days provides a greater reduction in the MAP. In non-anesthetized SHR rats, i.v administration of GASH promoted a biphasic effect, initially characterized by hypotension (ΔMAP= -39.40 ± 11.62) and bradycardia (ΔHR= -96.06 ± 44.34) followed by hypertension (ΔMAP= 69.4 ± 15.82) and tachycardia (ΔHR = 74.4 ± 35.95). Similar results occurred with LNAME hypertensive rats and normotensive rats. When comparing the results, the decrease in MAP is greater, and the bradycardia is smaller, in the L-NAME model and SHR model compared to normotensive rats. For the evaluation of hypotension and bradycardia in vivo, we performed the previous administration of L-NAME and atropine in normotensive rats and the hypotensive effect was attenuated and the bradycardia was abolished. Subsequently, experiments in rings of superior mesenteric artery isolated from normotensive rats showed that GASH-induced relaxation (Emax= 87.5 ± 6.5%) was significantly attenuated after removal of functional endothelium (Emax= 28.4 ± 4.9%), suggesting the involvement of endothelial-derived relaxing factors. Similar results were obtained with the previous incubation with L-NAME (Emax= 23.4 ± 5.1%) and ODQ (Emax= 11.8 ± 2.7%), suggesting the involvement of the NOS/NO/GMPc pathway in the relaxation. In rings of superior mesenteric artery isolated from normotensive rat, the previous incubation with indomethacin (Emax= 97 ± 4.1%) and atropine (Emax= 81 ± 3.9%) did not modify the relaxation induced by GASH, suggesting that arachidonic acid metabolites and M3 muscarinic receptor activation are not involved in this response. In endothelial cell line from rabbit aorta, GASH increased NO production (Δ= 82 ± 7.9%), which was reduced in the presence of L-NAME (Δ= 30.2 ± 12.1%), confirming the functional results. GASH promote the phosphorylation of eNOs and Akt in primary culture of endothelial cells from pig coronary by Western blot. Previous incubation with N-acetylcysteine in rings of superior mesenteric artery isolated from normotensive rats modified the relaxation induced by GASH (Emax= 32.5 ± 6.7%), suggesting the involvement of reactive oxygen species in the relaxation. GASH was able to increase levels of superoxide production in RAEC cell culture (Δ= 57 ± 4%). Using different methodological approaches in vivo and in vitro, this study suggests that GASH induces a antihypertensive effect in vivo in different models of hypertension, as well as an endothelium-dependent relaxing effect, probably secondary to an increase in the concentration of NO through the activation of the PI3k/Akt via, and suggest that these effects may be associated with the content of phenolic compounds found in GASH.
publishDate 2012
dc.date.none.fl_str_mv 2012-09-11
2012-02-14
2015-05-14T12:59:37Z
2018-07-21T00:24:52Z
2018-07-21T00:24:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv DELLACQUA, Melissa Negro. Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos. 2012. 124 f. Tese (Doutorado em Produtos Naturais e Sintéticos Bioativos) - Universidade Federal da Paraí­ba, João Pessoa, 2012.
https://repositorio.ufpb.br/jspui/handle/tede/6739
identifier_str_mv DELLACQUA, Melissa Negro. Avaliação dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto Garziera do Vale do São Francisco em ratos. 2012. 124 f. Tese (Doutorado em Produtos Naturais e Sintéticos Bioativos) - Universidade Federal da Paraí­ba, João Pessoa, 2012.
url https://repositorio.ufpb.br/jspui/handle/tede/6739
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal da Paraí­ba
BR
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraí­ba
BR
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Biblioteca Digital de Teses e Dissertações da UFPB
collection Biblioteca Digital de Teses e Dissertações da UFPB
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br|| diretoria@ufpb.br
_version_ 1801842915423551488